1
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin’s or Non-Hodgkin’s Lymphoma
Condition(s):LymphomaLast Updated:September 27, 2017Completed
Bone Marrow Ablation with Stem Cell Support: 66 Clinical Trials, Page 1 of 7
Hide Studies Not Open or Pending
2
High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:July 2, 2014Terminated
3
High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:August 23, 2013Completed
4
High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 1, 2010Completed
5
Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Condition(s):Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative DiseasesLast Updated:June 12, 2012Completed
6
Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer
Condition(s):Ovarian CancerLast Updated:May 30, 2013Completed
7
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
Condition(s):Brain Tumor; Central Nervous System TumorLast Updated:July 24, 2014Completed
8
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
Condition(s):Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:August 21, 2015Completed
9
Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer
Condition(s):Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell NeoplasmLast Updated:September 21, 2010Completed
10
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Condition(s):Drug/Agent Toxicity by Tissue/Organ; Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 3, 2012Terminated